A new study by scientists at deCODE Genetics, a subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene expression. The same variants are linked to various diseases and other human traits.
FILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA – Psychedelic Alpha
Reset Pharma has licensed Filament’s botanical psilocybin drug candidate for a phase 2 clinical trial studying demoralization syndrome VANCOUVER, BC, Aug. 31, 2023 /CNW/ –